Structure |
Chemical Name |
CAS |
MF |
|
4-Desmethyl 3-Methyl Vortioxetine Hydrochloride |
1293343-01-7 |
|
|
OFLOXACIN N-OXIDE (MIXTURE OF DIASTEREOMERS) |
104721-52-0 |
C18H20FN3O5 |
|
4-[[2-(2-Amino-4-thiazolyl)acetyl]amino]-benzeneacetic Acid |
1365244-64-9 |
C13H13N3O3S |
|
OCTAKIS-6-BROMO-6-DEOXY-GAMMA-CYCLODEXTRIN |
53784-84-2 |
C48H72Br8O32 |
|
2-ETHYNYLANILINE 98 |
52670-38-9 |
C8H7N |
|
Palbociclib Impurity 91 |
571191-15-6 |
C22H27N7O2 |
|
Ibrutinib Impurity 28 |
2213398-75-3 |
C18H15N5O |
|
Clopidogrel Impurity 60 |
1430373-12-8 |
C25H26ClNO6S |
|
Ozagrel Impurity F |
|
|
|
Ceftriaxone Sodium impurity 1 |
1214622-93-1 |
C10H12N2O5S |
|
Lasoprazole impurity |
|
|
|
Fluticasone Impurity 14 |
|
C25H31F3O5S |
|
Ritonavir EP Impurity U |
|
|
|
DexMedetoMidine IMpurity O |
|
|
|
Rivaroxaban Impurity 48 |
1414932-72-1 |
C21H20ClN3O4 |
|
Imatinib Impurity A |
|
|
|
Vonoprazan Impurity 19 |
|
|
|
Pregabalin Diacid |
1788341-42-3 |
C16H26N2O |
|
Dexamethasone Impurity A |
|
|
|
Olaparib Impurity 24 |
|
|
|
Topiroxostat Impurity 6 |
|
|
|
Irinotecan EP Impurity H |
|
|
|
Teneligliptin Impurity 4 |
|
|
|
Erlotinib Hydrochloride iMpurity 53 |
|
|
|
(3R,4S)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4- fluorophenyl)piperidine-1-carboxylate |
2389152-22-9 |
C26H24FNO5 |
|
Moxifloxacin EP Impurity K |
|
|
|
Anestagnate |
|
|
|
Trelagliptin IMpurity 33 |
|
|
|
Estradiol Impurity 1 |
57780-81-1 |
C18H24O4 |
|
Metoprolol IMpurity L |
|
C15H25NO3 |
|
Teneligliptin Impurity 14 |
|
|
|
Ampicillin EP Impurity P |
|
|
|
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, 1-methylethyl ester, (5E)- |
1563176-58-8 |
C25H34F2O5 |
|
Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R,5S)-tetrahydro-4-hydroxy-5-methyl-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester |
477877-98-8 |
C26H40O5 |
|
1H-1,2,4-Triazole-1-ethanol, α-(2,4-difluorophenyl)-α-(1H-1,2,4-triazol-1-ylmethyl)-, 4-oxide |
1997296-62-4 |
C13H12F2N6O2 |
|
Avatrombopag Impurity 32 |
|
|
|
(±)-N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetamidmonohydrochlorid |
73899-76-0 |
C16H25ClN2O4 |
|
Alvatrombopag Impurity 999 |
|
|
|
3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-1,6-dihydro-6-oxo-, hydrochloride (1:) |
570403-05-3 |
C23H26Cl3N5O2S2 |
|
Avatrombopag Impurity 49 |
|
|
|
5a-17-(3-Pyridyl)-16-androstene-3-one |
|
C24H31NO |
|
Avanafil IMpurity 6 |
|
|
|
3-Pyridinecarboxylic acid, 6-(4-carboxy-1-piperidinyl)-5-chloro- |
958457-83-5 |
C12H13ClN2O4 |
|
Abiraterone Impurity 9 |
165334-72-5 |
C24H31NO |
|
Afatinib Impurity 23 |
1314777-66-6 |
C8H4FN3O3 |
|
Afatinib impurity 31 |
|
|
|
Afatinib Impurity 10 |
|
|
|
2-Thiazolamine, 4-(4-bromo-2-thienyl)- |
81216-89-9 |
C7H5BrN2S2 |
|
6-bromo-4-((dimethylamino)methyl)-5-hydroxy-N,1-dimethyl-2-((phenylthio)methyl)-1H-indole-3-carboxamide |
|
|
|
Avatrombopag Impurity 40 |
|
|
|
((2R,3R,5S)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-4,4-difluoro-3-hydroxytetrahydrofuran-2-yl)methyl benzoate |
|
|
|
Avatrombopag Impurity 77 |
|
|
|
N-(4-((3-chloro-4-fluorophenyl)amino)-7-fluoroquinazolin-6-yl)-4-(dimethylamino)butanamide |
|
|
|
2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1R-cis)- |
136470-79-6 |
C14H18N6O |
|
(3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol N-Oxide Sulfate |
|
C24H31NO5S |
|
Abacavir Impurity E |
208762-35-0 |
C14H20N6O |
|
Avanafil iMpurity 3 |
|
|
|
Androst-16-en-3-ol, 17-(3-pyridinyl)-, acetate (ester),(3β,5α)- |
219843-76-2 |
C26H35NO2 |
|
Afatinib Impurity 19 |
1245555-42-3 |
C21H21ClFN5O2 |
|
rac-Valsartan EP Impurity B |
1894176-44-3 |
C31H35N5O3 |
|
Arbidol Impurity I |
153633-10-4 |
C22H24Br2N2O3S |
|
Afatinib Impurity 25 |
|
|
|
Afatinib impurity 28 |
|
|
|
Afatinib impurity 11/Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(5-Hydroxy-pyrrolidin-2-on-1-yl) Afatinib |
2223677-58-3 |
C22H20ClFN4O4 |
|
Vigabatrin Impurity 2 |
|
|
|
ethyl 6-bromo-2-(bromomethyl)-5-hydroxy-1-methyl-1H-indole-3-carboxylate |
149246-36-6 |
C13H13Br2NO3 |
|
2-Thiazolamine, 5-(4-cyclohexyl-1-piperazinyl)-4-(4,5-dichloro-2-thienyl)- |
570407-63-5 |
C17H22Cl2N4S2 |
|
Avatrombopag Impurity 37 |
|
|
|
Abiolone Impurity 24 |
|
|
|
AvatrombopagImpurity42 |
|
|
|
Avatrombopag Impurity 51 |
|
|
|
(S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-hydroxybut-2-enamide |
|
|
|
N-(3-chloro-4-fluorophenyl)-7-fluoro-6,8-dinitroquinazolin-4-amine |
|
|
|
5-chloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)-6-(4-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)piperidin-1-yl)nicotinamide |
|
|
|
1-(4-PIPERIDINYLCARBONYL)-4-PIPERIDINECARBOXYLIC ACID |
96053-48-4 |
C12H20N2O3 |
|
Afatinib Impurity 16 |
|
|
|
mixture of PD 312236 and PD 312237 |
|
|
|
Adefovir Impurity D |
|
|
|
Afatinib impurity 35 |
|
|
|
Macitentandesbromopyrimidine Impurity |
|
|
|
Avatrombopag Impurity 22 |
|
|
|
Avatrombopag Impurity 33 |
|
|
|
4-chloro-N-(3-chloro-4-fluorophenyl)-8-nitroquinazolin-7-amine |
|
|
|
Avatrombopag Impurity 59 |
|
|
|
5-(Propylthio)-1H-benzimidazol-2-amine |
80983-36-4 |
C10H13N3S |
|
3,5,3',5'-Tetraiodo Thyrolactic Acid |
7069-47-8 |
C15H10I4O5 |
|
Albendazole EP IMpurity F |
80983-45-5 |
C10H11N3O2S |
|
Avanafil IMpurity 7 |
|
|
|
Lesinurad Impurity |
|
|
|
Afatinib Impurity 21 |
2044709-72-8 |
C18H16F2N4O2 |
|
Adefovir Impurity 1 |
|
|
|
Abacavir |
141271-12-7 |
C10H14ClN5O |
|
Adefovir Impurity 10 |
|
|
|
Afatinib impurity 32 |
|
|
|
Avatrombopag Impurity 22 |
570403-14-4 |
C31H38Cl2N6O3S2 |
|
NA |
|
|
|
ethyl 6-bromo-4,7-bis((dimethylamino)methyl)-5-hydroxy-1-methyl-2-((phenylthio)methyl)-1H-indole-3-carboxylate |
|
|
|
4-Piperidinecarboxylic acid, 1-[5-[[[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]amino]carbonyl]-3-hydroxy-2-pyridinyl]- |
1290121-42-4 |
C29H35ClN6O4S2 |
|
2-Thiazolamine, 4-(5-bromo-4-chloro-2-thienyl)- |
1534575-19-3 |
C7H4BrClN2S2 |
|
Avatrombopag Impurity 24 |
|
|